| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Revenue | $1.55B | +5.4% |
| R&D Expense | $1.4M | +1.9% |
| SG&A Expense | $502.0M | +2.7% |
| Operating Income | $114.0M | +28.3% |
| Pre-tax Income | $56.6M | +113.2% |
| Income Tax | $16.3M | +75.2% |
| Net Income | $40.3M | +133.6% |
| EPS (Basic) | $0.20 | +122.2% |
| EPS (Diluted) | $0.20 |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.3M | -38.7% |
| Accounts Receivable | $114.9M | +4.7% |
| Inventory | $485.9M | +20.4% |
| Current Assets | $646.5M | +12.8% |
| Total Assets | $2.36B | +1.1% |
| Current Liabilities | $257.6M | +1.5% |
| Long-term Debt | $673.8M | -4.9% |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $105.2M | -42.6% |
| Investing Cash Flow | -$70.4M | +50.9% |
| Financing Cash Flow | -$52.2M | -33.0% |
| +122.2% |
| Total Liabilities |
| $1.13B |
| -1.8% |
| Stockholders' Equity | $1.23B | +3.9% |